AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 194 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $631,000 | +8.8% | 67,175 | -11.4% | 0.01% | 0.0% |
| Q2 2020 | $580,000 | +23.9% | 75,785 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $468,000 | -49.2% | 75,785 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $922,000 | -7.5% | 75,785 | -12.2% | 0.01% | -14.3% |
| Q3 2019 | $997,000 | +40.8% | 86,285 | +21.7% | 0.01% | +16.7% |
| Q2 2019 | $708,000 | +82.0% | 70,885 | +134.8% | 0.01% | +50.0% |
| Q1 2019 | $389,000 | -15.3% | 30,185 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $459,000 | -3.6% | 30,185 | +26.9% | 0.00% | +33.3% |
| Q3 2018 | $476,000 | +11.7% | 23,785 | +9.0% | 0.00% | 0.0% |
| Q2 2018 | $426,000 | -3.2% | 21,823 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $440,000 | -49.7% | 21,823 | -66.9% | 0.00% | -50.0% |
| Q4 2017 | $875,000 | +117.1% | 66,023 | +202.5% | 0.01% | +200.0% |
| Q3 2017 | $403,000 | +23.6% | 21,823 | +23.3% | 0.00% | -33.3% |
| Q2 2017 | $326,000 | -41.5% | 17,700 | -28.3% | 0.00% | -40.0% |
| Q1 2017 | $557,000 | -35.2% | 24,700 | 0.0% | 0.01% | -37.5% |
| Q4 2016 | $860,000 | +42.1% | 24,700 | 0.0% | 0.01% | +33.3% |
| Q3 2016 | $605,000 | +2.4% | 24,700 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $591,000 | +2.2% | 24,700 | 0.0% | 0.01% | +16.7% |
| Q1 2016 | $578,000 | – | 24,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |